These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 11584760)
1. [Caspofungin. A new antimycotic agents from the echinocandin group]. Hennemann A Med Monatsschr Pharm; 2001 Sep; 24(9):282-4. PubMed ID: 11584760 [No Abstract] [Full Text] [Related]
2. The role of caspofungin and the echinocandins in the antifungal armamentarium. Morrison VA Curr Opin Investig Drugs; 2002 Oct; 3(10):1432-6. PubMed ID: 12431014 [TBL] [Abstract][Full Text] [Related]
4. [First echinocandin on the market. New type of antifungal against Aspergillus & Co]. MMW Fortschr Med; 2002 Apr; 144 Suppl 1():83-4. PubMed ID: 12043093 [No Abstract] [Full Text] [Related]
5. Caspofungin: the first of a new class of antifungal agents. Valgus JM Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335 [No Abstract] [Full Text] [Related]
6. Caspofungin (Cancidas) for aspergillosis. Med Lett Drugs Ther; 2001 Jul; 43(1108):58-9. PubMed ID: 11445777 [No Abstract] [Full Text] [Related]
7. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Villanueva A; Arathoon EG; Gotuzzo E; Berman RS; DiNubile MJ; Sable CA Clin Infect Dis; 2001 Nov; 33(9):1529-35. PubMed ID: 11588698 [TBL] [Abstract][Full Text] [Related]
8. New type of antifungal approved for invasive aspergillosis. Thompson CA Am J Health Syst Pharm; 2001 Apr; 58(7):558, 560. PubMed ID: 11296601 [No Abstract] [Full Text] [Related]
9. Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. Voitl P; Scheibenpflug C; Weber T; Janata O; Rokitansky AM Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):632-4. PubMed ID: 12226700 [No Abstract] [Full Text] [Related]
10. Caspofungin versus amphotericin B for invasive candidiasis. Brown AL; Greig JR N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396 [No Abstract] [Full Text] [Related]
11. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans. Rubin MA; Carroll KC; Cahill BC Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012 [No Abstract] [Full Text] [Related]
13. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis. Chocarro MartÃnez A; Gonzalez A; Garcia I Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888 [No Abstract] [Full Text] [Related]
14. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin. Apostolidis J; Bouzani M; Platsouka E; Belasiotou H; Stamouli M; Harhalakis N; Boutati EI; Paniara O; Nikiforakis E Clin Infect Dis; 2003 May; 36(10):1349-50. PubMed ID: 12746788 [No Abstract] [Full Text] [Related]
15. Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus: rapid response to treatment with caspofungin and itraconazole. Safdar A Clin Infect Dis; 2002 May; 34(10):1415-7. PubMed ID: 11981740 [TBL] [Abstract][Full Text] [Related]
16. Hitting a new target with echinocandins. Why chase something else? Graybill JR Curr Opin Investig Drugs; 2001 Apr; 2(4):468-71. PubMed ID: 11566000 [No Abstract] [Full Text] [Related]
17. Federal Drug Administration panel recommends approval of Cancidas, Merck's investigational antifungal drug. J Assoc Nurses AIDS Care; 2001; 12(4):93-4. PubMed ID: 11486726 [No Abstract] [Full Text] [Related]
19. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B. Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850 [No Abstract] [Full Text] [Related]
20. New antifungal drugs and the pediatric cancer patient: current status of clinical development. Groll AH; Lehrnbecher T Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]